Dwarfism, Pituitary
Recent clinical, regulatory, research and industry developments relating to this disease.
Growth Hormone Deficiency: Health and Longevity.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Research-associated treatments
Drugs and agents co-studied with this disease across the research literature — associative, not necessarily established treatments. Number shows shared papers.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes4
- Dwarfism, Pituitary1
- Human Growth Hormone1
- Hypopituitarism1
- Longevity1
Leading journals2
- Endocrine reviews1
- Frontiers in endocrinology1
Leading researchers7
- Aguiar-Oliveira MH1
- Antoniazzi F1
- Bartke A1
- Cavarzere P1
- Guzzo A1
- Pietrobelli A1
- Zaffanello M1
Affiliations (unnormalised)4
- Federal University of Sergipe1
- School of Medicine1
- Southern Illinois University School of Medicine1
- University of Verona1
Reference
Authoritative identity, definition & identifiers.
A form of dwarfism caused by complete or partial GROWTH HORMONE deficiency, resulting from either the lack of GROWTH HORMONE-RELEASING FACTOR from the HYPOTHALAMUS or from the mutations in the growth hormone gene (GH1) in the PITUITARY GLAND. It is also known as Type I pituitary dwarfism. Human hypophysial dwarf is caused by a deficiency of HUMAN GROWTH HORMONE during development.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.